Carraro India IPO listing is set for December 30, following a final allotment on December 26. The IPO was subscribed 1.12 times, with QIBs at 2.21 times. The price range is ₹668 to ₹704. Funds raised will go to Carraro International S.

After the subscription of the IPO, the basis of allotment is likely to take place on December 26th ahead of listing on BSE and NSE. The latest grey market premium (GMP) of Carraro India IPO is flat, indicating a muted market debut.

Investors can also verify their Carrayor India IPO allotment status post-finalisation on the official websites of the BSE, NSE, or Link Intime India, the registrar for the issue

Ventive Hospitality, Senores Pharmaceuticals, and Carraro India IPOs will list on December 30. Senores Pharmaceuticals has a 93.69 times subscription, while Ventive shows a positive grey market premium.

Check Carraro India IPO allotment status today on NSE, BSE, or Link Intime. Follow simple steps to discover your share allocation!

The response to the Carraro India IPO has been lukewarm, with only 22% of the offering subscribed during the first two days of bidding. None of the categories were fully subscribed, with the retail segment receiving the highest bids at 35%.

The allotments for the issue that closed for subscription on 24 December 2024 is out. Here are steps to check status online, GMP as focus shifts to listing

Choose between Carraro India with its strong growth or Senores Pharma with high market demand. Decide your bet by!

Carraro India IPO GMP stood at nil at 9:32 a.m. on Dec. 19, according to InvestorGain. Going by the current GMP trend, Carraro India shares were likely to make a market debut at the upper price band of Rs 704. However, the GMP trend may be reversed once the IPO opens for subscription.